Our Webinars

Closing the Gap: Broadening Representation in Clinical Trials

Closing the Gap: Broadening Representation in Clinical Trials

Date: Thursday, September 30, 2021
Time: 11am EDT(NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
Length: 60 minutes

REGISTER

While the FDA has spent the past few decades promoting diversity in clinical trial patient populations, certain groups still remain underrepresented. Data shows that Black and Hispanic populations are consistently overlooked, even though the U.S. Census Bureau projects that by 2050, 42% of American older adults will be members of minority groups. As these populations continue to grow, it only further stresses the need for representation through all phases of research. Black patients account for 12% of new breast cancer cases in the United States but constituted only 3% of the participants in the breast cancer clinical trials that led to U.S. Food and Drug Administration (FDA) approvals between 2008-2018.

Aside from the obvious moral and ethical concerns over the lack of patient diversity, sponsor companies would greatly benefit from addressing underserved populations. Racial diversity in clinical trials enables the ability to conduct subgroup analyses based on drug metabolism and biomarker differences that will identify differences in biology, efficacy and tolerability between different racial groups of patients.

Trials can be conducted faster – resulting in sponsor cost reductions, increased trial participation rates, and ultimately produce more reliable safety and efficacy data. Yet while it is the goal of biotech and pharmaceutical companies to get their new drug or therapy to the market as quickly (and safely) as possible, it is a shared responsibility between sponsor companies, regulators, researchers, and clinical development partners to address the longstanding racial and ethnic disparities present in clinical research.

Register for this webinar on Thursday, September 30, at 11am EDT to hear Synteract’s Scott Treiber, Vice President, Strategic Development, and Ricki Fairley, CEO, TOUCH, The Black Breast Cancer Alliance, explore this topic in our upcoming webinar, Closing the Gap: Broadening Representation in Clinical Trials.

Speakers:

  • Scott Treiber, PhD, MBA, Vice President, Strategic Development, Synteract
  • Ricki Fairley, Chief Executive Officer, TOUCH, The Black Breast Cancer Alliance


Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract General Medicince Clinical Trial Leadership

Linda RawlingsContact us to find out more about our General Medicine expertise and experience Red Arrow

Linda Rawlings, MSc, FIBMS
VP General Medicine

Contact us to find out more about our General Medicine expertise and experience Red Arrow
x

Synteract Rare, Orphan, & Pediatric Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Pediatric and Rare and Orphan Diseases expertise and experience Red Arrow

Lisa Dilworth
VP, Strategic Development, Rare, Orphan and Pediatric Diseases

Contact us to find out more about our Rare, Orphan, & Pediatric Diseases expertise and experience Red Arrow
x

 

x

 

x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required